article thumbnail

New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue

The Pharma Data

Right now, no medication is approved specifically for pulmonary hypertension caused by ILD, said Dr. Steven Nathan, senior researcher on the new trial. Doctors are allowed to prescribe FDA-approved medications for unapproved uses when they believe it’s medically appropriate.). The complication may also shorten their lives.

Doctors 52
article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part ii)

pharmaphorum

Wanting next to explore the place of research in this discussion of equity and innovation excellence, he invited Catherine Elliott to speak. And in the UK over 30% of clinical trials funded has one European partner at least. After all, cancer research is global and innovation, too, is global.

Nurses 97